K. Iwatsuki

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Keiji Iwatsuki, Kei-ji Iwatsuki, K Iwatsuki, Keij Iwatsuki, K. Iwatsuki
Publication record
532 papers · 14,099 citations · H-index 60

PAPERS

Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells
20231 citationsauthor #2
Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy
20238 citationsauthor #9
Rituximab therapy for intractable pemphigus: A multicenter, open‐label, single‐arm, prospective study of 20 Japanese patients
20223 citationsauthor #10
Efficacy and Safety of Oral Bexarotene for Japanese Patients with Mycosis Fungoides : A Retrospective Case-Series Study of a Single Medical Center in Japan
20210 citationsauthor #6
Analysis of clonality in cutaneous B‐cell lymphoma and B‐cell pseudolymphoma using skin flow cytometry: Comparison of immunophenotyping and gene rearrangement studies
20217 citationsauthor #6
Functional Depletion of HSP72 by siRNA and Quercetin Enhances Vorinostat-Induced Apoptosis in an HSP72-Overexpressing Cutaneous T-Cell Lymphoma Cell Line, Hut78
202111 citationsauthor #4
Improved quality of life of patients with generalized pustular psoriasis in Japan: A cross‐sectional survey
202017 citationsauthor #3
Transient and zosteriform vancomycin-induced linear IgA bullous dermatosis in a patient undergoing haemodialysis: drug-mediated IgA immunoreactivity against type VII collagen
20202 citationsauthor #5
The aim of the measurement of Epstein‐Barr virus DNA in hydroa vacciniforme and hypersensitivity to mosquito bites
202010 citationsauthor #2
Recovery from recalcitrant malignant peripheral nerve sheath tumor: A combination of Mohs paste‐aided surgical debridement and chemotherapy
20190 citationsauthor #4
Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders
201922 citationsauthor #1
Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti‐aminoacyl tRNA synthetase antibodies
201923 citationsauthor #11
Results of a nationwide epidemiologic survey of autosomal recessive congenital ichthyosis and ichthyosis syndromes in Japan.
20199 citationsauthor #5
168 Coexpression of TCR/CD3 complex and natural killer cell markers, CD16 and/or CD56, by Epstein-Barr virus-infected T-cells in hydroa vacciniforme-like lymphoproliferative disorders
20190 citationsauthor #1
Defective Epstein–Barr virus in chronic active infection and haematological malignancy
2019191 citationsauthor #34
Pathogenic link among plasma cell dyscrasia－related syndromes
20190 citationsauthor #1
Expression of Epidermal Adhesion Molecules in the Lesional Skin of a Patient with Bullous Impetigo
20190 citationsauthor #4
Publisher Correction: Defective Epstein–Barr virus in chronic active infection and haematological malignancy
20190 citationsauthor #34
Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting
201950 citationsauthor #2
The expression of cell adhesion molecule 1 and its splicing variants in Sézary cells and cell lines from cutaneous T‐cell lymphoma
20199 citationsauthor #18
1792. Viral DNA Loads in Various Blood Components of Patients with EBV-Positive T/NK Cell Lymphoproliferative Diseases
20190 citationsauthor #4
Viral DNA loads in various blood components of patients with Epstein-Barr virus-positive T/NK cell lymphoproliferative diseases.
201916 citationsauthor #4
Publisher Correction: Defective Epstein–Barr virus in chronic active infection and haematological malignancy
20195 citationsauthor #34
Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)
201964 citationsauthor #8
Toll‐like receptor signalling induces the expression of serum amyloid A in epidermal keratinocytes and dermal fibroblasts
201913 citationsauthor #6
Cell adhesion molecule 1 (CADM1) can be a biomarker for Sézary syndrome
20190 citationsauthor #5
Long‐term efficacy and safety of bexarotene for Japanese patients with cutaneous T‐cell lymphoma: The results of a phase 2 study (B‐1201)
201915 citationsauthor #14
Two cases of malignant melanoma of the esophagus treated with nivolumab
20190 citationsauthor #4
A cat bite-induced skin abscess associated with Bacteroides pyogenes, identified by mass spectrometry
20182 citationsauthor #3
Clinical and Laboratory Markers Associated With Relapse in Cutaneous Polyarteritis Nodosa
201823 citationsauthor #7
Papuloerythroderma‐like cutaneous involvement of a CD62L− subclone of T‐cell prolymphocytic leukemia
20185 citationsauthor #12
Promising therapeutic option for cutaneous plasmacytosis: 308‐nm excimer lamp
20182 citationsauthor #8
Analysis of Advanced Melanomas Changed from Immune Checkpoint Blockade Therapy to Palliative Care
20180 citationsauthor #5
Long‐term efficacy and safety results from an open‐label phase III study (UNCOVER‐J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab
201831 citationsauthor #17
High calcium enhances the expression of double‐stranded RNA sensors and antiviral activity in epidermal keratinocytes
20188 citationsauthor #5
EB virus-associated T/NK lymphoproliferative disorders in East Asia, and South and Central America : Special reference to hydroa vacciniforme and hypersensitivity to mosquito bites
20180 citationsauthor #1
Clinical and Driver Mutation Analysis of Melanoma of Unknown Primary and a Review of Japanese Literature
20180 citationsauthor #7
Hydroa vacciniforme and hydroa vacciniforme-like lymphoproliferative disorder: Disease spectrum, responsible T-cell subsets and prognosis
20180 citationsauthor #1
Ethosuximide‐induced Stevens–Johnson syndrome: Beneficial effect of early intervention with high‐dose corticosteroid therapy
20187 citationsauthor #7
The Presence of Defective Epstein-Barr Virus (EBV) Infection in Patients with EBV-Associated Hematological Malignancy
20181 citationsauthor #33
Long‐term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open‐label, phase 3 study (UNCOVER‐J)
201862 citationsauthor #3
The synergistic activities of the combination of tumour necrosis factor‐α, interleukin‐17A and interferon‐γ in epidermal keratinocytes
201810 citationsauthor #5
A Case of Multiple Segmental Schwannomas
20180 citationsauthor #5
An effective and promising treatment with adalimumab for impetigo herpetiformis with postpartum flare‐up
20188 citationsauthor #9
HSP72 functionally inhibits the anti-neoplastic effects of HDAC inhibitors.
20184 citationsauthor #6
Speckled lentiginous naevus: understanding the process of development and regression
20180 citationsauthor #1
Analysis of All 34 Exons of the SPINK5 Gene in Japanese Atopic Dermatitis Patients.
201814 citationsauthor #15
Toll-like receptor signaling induces the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
201811 citationsauthor #6
Autophagy in malnutrition‐associated dermatoses
20185 citationsauthor #7
Serum Carcinoembryonic Antigen Level as a Marker for Advanced Stage and Chemotherapeutic Response in Extramammary Paget's Disease.
20184 citationsauthor #6
Leukocytoclastic vasculitis associated with immunoglobulin A lambda monoclonal gammopathy of undetermined significance: A case report and review of previously reported cases
20188 citationsauthor #3
Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP
2018231 citationsauthor #18
Epstein–Barr virus‐positive mucocutaneous ulcer in a patient with polycythemia vera treated with oral hydroxyurea
20182 citationsauthor #8
Microbiome, Dysbiosis, and Atopic Dermatitis
20181 citationsauthor #1
Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open‐label, single‐arm, phase 1/2 study on 10 Japanese patients
201823 citationsauthor #10
A Case of Psoriasis Complicated by Breast Cancer after Systemic Treatments Including Biologics.
20183 citationsauthor #6
Japanese Dermatological Association Guidelines: Guidelines for the treatment of acne vulgaris 2017
201870 citationsauthor #3
TypeD(CD8+) lymphomatoid papulosis in a patient with classic (CD4+) mycosis fungoides
20182 citationsauthor #7
Regional incidences of adult T‐cell leukemia/lymphoma with cutaneous involvement in Japan
20185 citationsauthor #3
Indolent hematodermic CD4+ T-cell lymphoma lacking surface CD3 expression: Structural and functional deficiency of T-cell receptor/CD3 complex
20180 citationsauthor #1
An unusual clinical presentation of lupus erythematosus tumidus localized on the thigh
20172 citationsauthor #8
Narrow-band UVB for pretibial (necrobiosis lipoidica-like) involvement of cutaneous sarcoidosis: a promising therapeutic option
20171 citationsauthor #4
The Involvement of Serum Amyloid A in Psoriatic Inflammation.
201717 citationsauthor #5
Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations
201770 citationsauthor #17
Usefulness of serum 5‐S‐cysteinyl‐dopa as a biomarker for predicting prognosis and detecting relapse in patients with advanced stage malignant melanoma
201713 citationsauthor #7
Two arginine residues in the COOH‐terminal of human β‐defensin‐3 constitute an essential motif for antimicrobial activity and IL‐6 production
201716 citationsauthor #7
Phenotypic analysis of circulating T‐cell subset and its association with burden of skin disease in patients with chronic actinic dermatitis: a hematologic and clinicopathologic study of 20 subjects
20178 citationsauthor #4
Prognostic value of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography in patients with cutaneous angiosarcoma: A retrospective study of 18 cases
201717 citationsauthor #7
The expression of serine protease inhibitors are induced by TNF-.ALPHA. and IL-17A in skin inflammatory diseases
20170 citationsauthor #5
United States Patent ( 19 ) Okonogi et al . 54 ) METHOD FOR PREPARING MILK SHAKE BEVERAGE 75 )
20170 citationsauthor #1
The expression of serine protease inhibitors in epidermal keratinocytes is increased by calcium, but not 1,25(OH)2 vitamin D3 or retinoic acid
20171 citationsauthor #5
Warfarin‐induced skin necrosis accompanied by aggravation of vasculitis in a patient with cutaneous arteritis
20171 citationsauthor #4
Markedly elevated EBV DNA load in plasma predicts the occurrence of HPS in hydroa vacciniforme and hypersensitivity to mosquito bites
20170 citationsauthor #4
Persistent elevation of serum interleukin-6 and serum amyloid A levels in patients with recessive dystrophic epidermolysis bullosa
20173 citationsauthor #7
019 Distinct clinicopathologic and radiological manifestations of the skin, lung, and muscle diseases in patients with dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies
20170 citationsauthor #8
Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma
2017112 citationsauthor #10
TLR signaling regulates the expression of serine protease inhibitors in epidermal keratinocytes
20170 citationsauthor #5
Clinical outcomes of primary cutaneous anaplastic large cell lymphoma: data from a single Japanese centre
20172 citationsauthor #10
Expression of serine protease inhibitors in epidermal keratinocytes is increased by calcium but not 1,25‐dihydroxyvitamin D3 or retinoic acid
201717 citationsauthor #5
Prognostic value of 18 F-FDG PET / CT in patients with cutaneous angiosarcoma : a retrospective study of 18 cases
20170 citationsauthor #8
Successful use of etoposide for pyoderma gangrenosum associated with myelodysplastic syndrome and trisomy 8: cytokine profiles during treatment
20176 citationsauthor #8
Clotting time-dependent pseudohyperkalemia associated with Sézary syndrome.
20170 citationsauthor #4
Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T‐cell lymphomas
201735 citationsauthor #14
Possible macrophage activation in melanoma patients receiving combined kinase inhibitor therapy following anti-PD-1 therapy: a cytokine profiling study of two cases.
20178 citationsauthor #4
Comparative study on driver mutations in primary and metastatic melanomas at a single Japanese institute: A clue for intra- and inter-tumor heterogeneity.
201724 citationsauthor #11
Neonatal-Onset Hereditary Coproporphyria: A New Variant of Hereditary Coproporphyria.
20172 citationsauthor #9
EP-1377: Single institutional experience of the treatment of angiosarcoma of the scalp
20170 citationsauthor #11
232 New nonsynonymous variants of SPINK5 gene in Japanese atopic dermatitis patients
20170 citationsauthor #4
Rapid multiresidue determination of pesticides in livestock muscle and liver tissue via modified QuEChERS sample preparation and LC-MS/MS
201712 citationsauthor #2
A case of extramammary Paget's disease treated with chemotherapy based on a sensitivity test for anticancer agents
20160 citationsauthor #6
Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52‐week, open‐label, phase 3 study (UNCOVER‐J)
2016191 citationsauthor #17
Peripher al immunological toler ance in molluscum contagiosum and induction of p53-dependent apoptosis
20160 citationsauthor #11
Cathelicidin peptide LL-37 induces UVB-triggered inflammasome activation and angiogenesis: Possible implications for rosacea
20160 citationsauthor #5
264 Patients with pemphigus foliaceus may retain antibody reactivity against calcium dependent epitopes of desmoglein 1 in remission
20160 citationsauthor #6
Terminal differentiation of keratinocytes enhances TLR 3 expression and anti-viral activity
20161 citationsauthor #3
Distinct lymphocyte subsets responsible for classical and systemic hydroa vacciniforme
20160 citationsauthor #8
Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug‐induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms
201620 citationsauthor #10
Autoantibody profile and clinical manifestations related to anti-synthetase syndrome
20160 citationsauthor #7
Metastatic Cutaneous Apocrine Adenocarcinoma Treated With a Combination of Pertuzumab-Based Targeted Therapy and Taxane Chemotherapy: A Case Report.
201624 citationsauthor #5
Epitope reduction of anti-desmoglein 1 autoantibodies in pemphigus foliaceus patients sera during clinical stages
20160 citationsauthor #8

TIMELINE

1977 5 citations

1980 27 citations

1982 226 citations

1983 113 citations

1984 35 citations

1985 104 citations

1986 187 citations

1987 44 citations

1988 36 citations

1989 28 citations

1990 9 citations

1991 88 citations

1992 13 citations

1993 60 citations

1994 141 citations

1995 22 citations

1996 53 citations

1997 86 citations

1998 44 citations

1999 222 citations

2000 125 citations

2001 1,128 citations

2002 414 citations

2003 725 citations

2004 332 citations

2005 1,268 citations

2006 946 citations

2007 628 citations

2008 389 citations

2009 1,198 citations

2010 855 citations

2011 588 citations

2012 1,178 citations

2013 349 citations

2014 490 citations

2015 222 citations

2016 343 citations

2017 367 citations

2018 542 citations

2019 417 citations

2020 29 citations

2021 18 citations

2022 3 citations

2023 9 citations

K. Iwatsuki

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT